In medically indicated weight loss, attention is typically focused on the associated health benefits. However, recent ...

Obesity, defined by a BMI over 30, significantly impacts dermatological health due to excess adipose tissue's endocrine ...

Researchers found that lower lean muscle mass and higher intermuscular adipose tissue acted as imaging-visible markers that ...

Below are a few more promising studies of weight-loss drugs. Combining bimagrumab, an investigational human monoclonal ...

An article published in the journal Nature Metabolism presents an experimental drug that stimulates adipose tissue cells to ...

Findings from two groundbreaking studies highlight potential pharmacological and biosensor solutions for muscle mass preservation in patients undergoing obesity treatment therapy. Results from the ...

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare ...

An article published in the journal Nature Metabolism presents an experimental drug that stimulates adipose tissue cells to produce heat through a ...

Supercede Therapeutics, Inc., a startup biotech company focused on small molecule drug development, today announced preclinical efficacy data from its lead therapeutic program to treat obesity.

We congratulate researchers at MedH who have been awarded CIMED project grants for the period 2026-2028.The following researchers at the Department ...

Obesity doesn’t just increase your risk of metabolic diseases it may also raise the risk of developing and progressing ...